TY - JOUR
T1 - Patterns of early allograft dysfunction in adult live donor liver transplantation
T2 - The A2ALL experience
AU - Pomposelli, James J.
AU - Goodrich, Nathan P.
AU - Emond, Jean C.
AU - Humar, Abhinav
AU - Baker, Talia B.
AU - Grant, David R.
AU - Fisher, Robert A.
AU - Roberts, John P.
AU - Olthoff, Kim M.
AU - Gillespie, Brenda W.
AU - Merion, Robert M.
N1 - Publisher Copyright:
© 2016 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2016/6/21
Y1 - 2016/6/21
N2 - Background. Early allograft dysfunction (EAD) after living donor liver transplantation (LDLT) has often been attributed to inadequate graft size, and termed small-for-size syndrome. Early allograft dysfunction definitions include a variable constellation of findings, including hyperbilirubinemia, coagulopathy, encephalopathy, and ascites formation. Among putative causes of EAD after LDLTare excessive portal pressure and/or flow. Our objective was to evaluate patterns of EAD after LDLT.Methods. In this study, 631 LDLT recipients were monitored for complications, EAD (defined by postoperative day 7 bilirubin >10 mg/dL or international normalized ratio >1.6), and graft failure. Approximately 200 had portal venous and arterial pressure and flowmeasurements before and after LDLT. Portal inflow modification (splenic artery ligation, hemiportocaval shunt, or splenectomy) was performed at the discretion of the operating surgeon. Associations between EAD and recipient, donor, and transplant factors were examined using multivariable logistic regression. Results. Risk of EAD was associated with left lobe grafts, lower graft weight among left lobes, higher preoperative bilirubin, higher portal reperfusion pressure, higher donor age, and higher donor body mass index. The risk of graft loss within the first 90 days was 5.2 times higher for recipients with EAD versus those without EAD (P < 0.001). Conclusions. Early allograft dysfunction can be defined using postoperative day 7 laboratory values that are highly predictive of early graft failure within 90 days. Risk factors associated with EAD after LDLT include: graft type and size, preoperative bilirubin, portal reperfusion pressure, donor age, and donor body mass index.
AB - Background. Early allograft dysfunction (EAD) after living donor liver transplantation (LDLT) has often been attributed to inadequate graft size, and termed small-for-size syndrome. Early allograft dysfunction definitions include a variable constellation of findings, including hyperbilirubinemia, coagulopathy, encephalopathy, and ascites formation. Among putative causes of EAD after LDLTare excessive portal pressure and/or flow. Our objective was to evaluate patterns of EAD after LDLT.Methods. In this study, 631 LDLT recipients were monitored for complications, EAD (defined by postoperative day 7 bilirubin >10 mg/dL or international normalized ratio >1.6), and graft failure. Approximately 200 had portal venous and arterial pressure and flowmeasurements before and after LDLT. Portal inflow modification (splenic artery ligation, hemiportocaval shunt, or splenectomy) was performed at the discretion of the operating surgeon. Associations between EAD and recipient, donor, and transplant factors were examined using multivariable logistic regression. Results. Risk of EAD was associated with left lobe grafts, lower graft weight among left lobes, higher preoperative bilirubin, higher portal reperfusion pressure, higher donor age, and higher donor body mass index. The risk of graft loss within the first 90 days was 5.2 times higher for recipients with EAD versus those without EAD (P < 0.001). Conclusions. Early allograft dysfunction can be defined using postoperative day 7 laboratory values that are highly predictive of early graft failure within 90 days. Risk factors associated with EAD after LDLT include: graft type and size, preoperative bilirubin, portal reperfusion pressure, donor age, and donor body mass index.
UR - http://www.scopus.com/inward/record.url?scp=84976315462&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84976315462&partnerID=8YFLogxK
U2 - 10.1097/TP.0000000000001240
DO - 10.1097/TP.0000000000001240
M3 - Article
C2 - 27326811
AN - SCOPUS:84976315462
SN - 0041-1337
VL - 100
SP - 1490
EP - 1499
JO - Transplantation
JF - Transplantation
IS - 7
ER -